Clinical trial
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
To better understand how IL-2 causes tumors to shrink.
| Category | Value |
|---|---|
| Study start date | 2006-03-16 |